eTable 2.
Adverse events occurring in ≥ 10% of participants (N=150).
| Adverse Event | Placebo N=49 | Gabapentin 900mg N=54 | Gabapentin 1800mg N=47 |
|---|---|---|---|
| Fatigue | 12 (24%) | 13 (24%) | 9 (19%) |
| Insomnia | 11 (22%) | 10 (19%) | 6 (13%) |
| Headache | 8 (16%) | 7 (13%) | 6 (13%) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.